Skip to main navigation Skip to search Skip to main content

Celldex: Phase I/II Study of Glembatumumb Vedotin in Patients with gpNMB-Expressing, Advanced or Metastatic Squamous Cell Carcinoma of the Lung

Project: Research

Project Details

StatusFinished
Effective start/end date03/31/1603/7/19

Funding

  • Alpha Oncology: $20,425.00